{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:21Z","timestamp":1786979961690,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Catalan Rheumatic League"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00296-020-04598-1","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:04:17Z","timestamp":1589807057000},"page":"1473-1480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A questionnaire-based study on contraceptive practice in patients with rheumatic disease found no significant difference in age-matched healthy controls"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2541-5766","authenticated-orcid":false,"given":"Andrea","family":"Pluma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela C.","family":"Micu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-3620","authenticated-orcid":false,"given":"Antonio","family":"Juli\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-3854","authenticated-orcid":false,"given":"Sara","family":"Marsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1134-993X","authenticated-orcid":false,"given":"Frauke","family":"F\u00f6rger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3211-1974","authenticated-orcid":false,"given":"Monika","family":"\u00d8stensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"4598_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/acr.20402","volume":"63","author":"J Yazdany","year":"2011","unstructured":"Yazdany J, Trupin L, Kaiser R et al (2011) Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Arthritis Care Res (Hoboken) 63:358\u2013365. https:\/\/doi.org\/10.1002\/acr.20402","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4598_CR2","first-page":"1266","volume":"34","author":"M \u00d8stensen","year":"2007","unstructured":"\u00d8stensen M, von Esebeck M, Villiger PM (2007) Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol 34:1266\u20131269","journal-title":"J Rheumatol"},{"key":"4598_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.contraception.2010.02.003","volume":"82","author":"SL Farr","year":"2010","unstructured":"Farr SL, Folger SG, Paulen ME, Curtis KM (2010) Safety of contraceptive methods for women with rheumatoid arthritis: a systematic review. Contraception 82:64\u201371. https:\/\/doi.org\/10.1016\/j.contraception.2010.02.003","journal-title":"Contraception"},{"key":"4598_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrrheum.2011.54","volume":"7","author":"M Ostensen","year":"2011","unstructured":"Ostensen M (2011) Connective tissue diseases: contraception counseling in SLE\u2014an often forgotten duty? Nat Rev Rheumatol 7:315\u2013316. https:\/\/doi.org\/10.1038\/nrrheum.2011.54","journal-title":"Nat Rev Rheumatol"},{"key":"4598_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2307\/2939202","volume":"24","author":"K Ringheim","year":"1993","unstructured":"Ringheim K (1993) Factors that determine prevalence of use of contraceptive methods for men. Stud Fam Plann 24:87\u201399","journal-title":"Stud Fam Plann"},{"key":"4598_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.contraception.2017.10.003","volume":"97","author":"ML Kavanaugh","year":"2018","unstructured":"Kavanaugh ML, Jerman J (2018) Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014. Contraception 97:14\u201321. https:\/\/doi.org\/10.1016\/j.contraception.2017.10.003","journal-title":"Contraception"},{"key":"4598_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.rdc.2016.12.001","volume":"43","author":"LR Sammaritano","year":"2017","unstructured":"Sammaritano LR (2017) Contraception in patients with rheumatic disease. Rheum Dis Clin N Am 43:173\u2013188. https:\/\/doi.org\/10.1016\/j.rdc.2016.12.001","journal-title":"Rheum Dis Clin N Am"},{"key":"4598_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/1756-185X.12338","volume":"17","author":"E Dalkilic","year":"2014","unstructured":"Dalkilic E, Tufan AN, Oksuz MF et al (2014) Comparing female-based contraceptive methods in patients with systemic lupus erythematosus, rheumatoid arthritis and a healthy population. Int J Rheum Dis 17:653\u2013657. https:\/\/doi.org\/10.1111\/1756-185X.12338","journal-title":"Int J Rheum Dis"},{"key":"4598_CR9","first-page":"2310","volume":"28","author":"JF Skomsvoll","year":"2001","unstructured":"Skomsvoll JF, Ostensen M, Baste V, Irgens LM (2001) Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women. J Rheumatol 28:2310\u20132314","journal-title":"J Rheumatol"},{"key":"4598_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/rheumatology\/keq458","volume":"50","author":"M Wallenius","year":"2011","unstructured":"Wallenius M, Skomsvoll JF, Irgens LM et al (2011) Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford) 50:1162\u20131167. https:\/\/doi.org\/10.1093\/rheumatology\/keq458","journal-title":"Rheumatology (Oxford)"},{"key":"4598_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/acr.21593","volume":"64","author":"MEB Clowse","year":"2012","unstructured":"Clowse MEB, Chakravarty E, Costenbader KH et al (2012) Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 64:668\u2013674. https:\/\/doi.org\/10.1002\/acr.21593","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4598_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1783\/147118901101195029","volume":"27","author":"L Lakasing","year":"2001","unstructured":"Lakasing L, Khamashta M (2001) Contraceptive practices in women with systemic lupus erythematosus and\/or antiphospholipid syndrome: what advice should we be giving? J Fam Plann Reprod Health Care 27:7\u201312","journal-title":"J Fam Plann Reprod Health Care"},{"key":"4598_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/1756-185X.12996","volume":"20","author":"P Galappatthy","year":"2017","unstructured":"Galappatthy P, Jayasinghe JDD, Paththinige SC et al (2017) Pregnancy outcomes and contraceptive use in patients with systemic lupus Erythematosus, rheumatoid arthritis and women without a chronic illness: a comparative study. Int J Rheum Dis 20:746\u2013754. https:\/\/doi.org\/10.1111\/1756-185X.12996","journal-title":"Int J Rheum Dis"},{"key":"4598_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/BOR.0000000000000044","volume":"26","author":"M \u00d8stensen","year":"2014","unstructured":"\u00d8stensen M (2014) Contraception and pregnancy counselling in rheumatoid arthritis. Curr Opin Rheumatol 26:302\u2013307. https:\/\/doi.org\/10.1097\/BOR.0000000000000044","journal-title":"Curr Opin Rheumatol"},{"key":"4598_CR15","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/acr.23724","volume":"71","author":"M Birru Talabi","year":"2019","unstructured":"Birru Talabi M, Clowse MEB, Blalock SJ et al (2019) Contraception use among reproductive-age women with rheumatic diseases. Arthritis Care Res (Hoboken) 71:1132\u20131140. https:\/\/doi.org\/10.1002\/acr.23724","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4598_CR16","doi-asserted-by":"publisher","unstructured":"Bassol S, Cravioto MC, Durand M et al (2000) Mesigyna once-a-month combined injectable contraceptive: experience in Latin America. Contraception 61:309\u2013316. https:\/\/doi.org\/10.1016\/s0010-7824(00)00109-8","DOI":"10.1016\/s0010-7824(00)00109-8"},{"key":"4598_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0961203306071706","volume":"15","author":"CN Pisoni","year":"2006","unstructured":"Pisoni CN, Cuadrado MJ, Khamashta MA, Hunt BJ (2006) Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil). Lupus 15:877\u2013880. https:\/\/doi.org\/10.1177\/0961203306071706","journal-title":"Lupus"},{"key":"4598_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/01443615.2013.817982","volume":"34","author":"T Banas","year":"2014","unstructured":"Banas T, Hadyla-Banas I, Pity\u0144ski K et al (2014) Use of contraception by women treated with leflunomide due to rheumatic arthritis. J Obstet Gynaecol 34:60\u201364. https:\/\/doi.org\/10.3109\/01443615.2013.817982","journal-title":"J Obstet Gynaecol"},{"key":"4598_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-4755-11-21","volume":"11","author":"A Kabagenyi","year":"2014","unstructured":"Kabagenyi A, Jennings L, Reid A et al (2014) Barriers to male involvement in contraceptive uptake and reproductive health services: a qualitative study of men and women\u2019s perceptions in two rural districts in Uganda. Reprod Health 11:21. https:\/\/doi.org\/10.1186\/1742-4755-11-21","journal-title":"Reprod Health"},{"key":"4598_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OAJC.S126771","volume":"8","author":"RE Zigler","year":"2017","unstructured":"Zigler RE, Peipert JF, Zhao Q et al (2017) Long-acting reversible contraception use among residents in obstetrics\/gynecology training programs. Open Access J Contracept 8:1\u20137. https:\/\/doi.org\/10.2147\/OAJC.S126771","journal-title":"Open Access J Contracept"},{"key":"4598_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/OAJC.S80683","volume":"6","author":"BM Afolabi","year":"2015","unstructured":"Afolabi BM, Ezedinachi EN, Arikpo I et al (2015) Knowledge, non-use, use and source of information on contraceptive methods among women in various stages of reproductive age in rural Lagos, Southwest Nigeria. Open Access J Contracept 6:65\u201375. https:\/\/doi.org\/10.2147\/OAJC.S80683","journal-title":"Open Access J Contracept"},{"key":"4598_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/13625187.2017.1304534","volume":"22","author":"K Freilich","year":"2017","unstructured":"Freilich K, Holton S, Rowe H et al (2017) Sociodemographic characteristics associated with the use of effective and less effective contraceptive methods: findings from the understanding fertility management in contemporary Australia survey. Eur J Contracept Reprod Health Care 22:212\u2013221. https:\/\/doi.org\/10.1080\/13625187.2017.1304534","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"4598_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nrrheum.2017.102","volume":"13","author":"M \u00d8stensen","year":"2017","unstructured":"\u00d8stensen M (2017) Sexual and reproductive health in rheumatic disease. Nat Rev Rheumatol 13:485\u2013493. https:\/\/doi.org\/10.1038\/nrrheum.2017.102","journal-title":"Nat Rev Rheumatol"},{"key":"4598_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76:476\u2013485. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04598-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04598-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04598-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:30:06Z","timestamp":1621279806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04598-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4598"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04598-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"21 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Pluma Sanjurjo reports received the First Research Prize for the social impact of Rheumatic Diseases from Catalan Rheumatic League. Dr. Micu has nothing to disclose. Dr. Juli\u00e0 has nothing to disclose. Dr. Marsal has nothing to disclose. Dr. F\u00f6rger has nothing to disclose. Dr. \u00d8stensen reports during the last 36\u00a0months speaker fees from Novartis, Roche, New Bridge, and UCB. She has been consultant for advisory board for Pfizer and for Galapagos pharmaceutical company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Rehabilitation Clinical Hospital, Cluj-Napoca, approved the study protocol (Nr. 6422\/Date 12.02.2015). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The ethics committee officer in Bern, Switzerland and in Barcelona, Spain reviewed the project protocol and questionnaire and confirmed that ethical committee approval was not required for this study conducted anonymously and without access to patient identification. Their consent was initially given verbally, but they provided a written confirmation of their decision on our request before submission of the manuscript. The Ethics Committee of Vall d\u2019Hebron University Hospital approved the study (Acta. 345\/Date 27.06.2018). The Ethics Committee of University Hospital Inselspital, Bern approved the study (Req-2019-00143\/Date 19.02.2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Verbal informed consent was obtained prior to completing the questionnaire.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}